CN115006509A - Chinese medicinal formula for treating uterine diseases - Google Patents
Chinese medicinal formula for treating uterine diseases Download PDFInfo
- Publication number
- CN115006509A CN115006509A CN202111660526.9A CN202111660526A CN115006509A CN 115006509 A CN115006509 A CN 115006509A CN 202111660526 A CN202111660526 A CN 202111660526A CN 115006509 A CN115006509 A CN 115006509A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- mixing
- powder
- treating uterine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000016599 Uterine disease Diseases 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 5
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 5
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 5
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 5
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 5
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 5
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 5
- 235000011477 liquorice Nutrition 0.000 claims abstract description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 5
- 240000000031 Achyranthes bidentata Species 0.000 claims abstract description 4
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 4
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 4
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 4
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 4
- 235000008397 ginger Nutrition 0.000 claims abstract description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract 2
- 240000002045 Guettarda speciosa Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 15
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 210000001113 umbilicus Anatomy 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 7
- 208000019255 Menstrual disease Diseases 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 6
- 206010049677 Salpingo-oophoritis Diseases 0.000 abstract description 6
- 230000004087 circulation Effects 0.000 abstract description 6
- 208000025661 ovarian cyst Diseases 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000004291 uterus Anatomy 0.000 abstract description 6
- 238000010792 warming Methods 0.000 abstract description 6
- 208000004145 Endometritis Diseases 0.000 abstract description 4
- 230000003628 erosive effect Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 description 7
- 244000061520 Angelica archangelica Species 0.000 description 3
- 240000007890 Leonurus cardiaca Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 244000150195 Cyperus longus Species 0.000 description 1
- 235000018109 Cyperus longus Nutrition 0.000 description 1
- 244000075634 Cyperus rotundus Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000005010 Scirpus paludosus Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicine prescription for treating uterine diseases is disclosed, wherein the traditional Chinese medicine prescription comprises the following raw materials in parts by weight: 6-12g of curcuma zedoary, 6-15g of rhizoma sparganii, 5-12g of motherwort herb, 2-10g of fructus evodiae, 1-6g of fried dried ginger, 2-10g of folium artemisiae argyi, 3-9g of achyranthes bidentata, 5-12g of angelica, 3-9g of moutan bark, 3-9g of rhizoma corydalis, 3-9g of rhizoma cyperi, 3-9g of radix paeoniae alba, 3-9g of salvia miltiorrhiza, 3-9g of cassia twig, 3-9g of ligusticum wallichii, 1-6g of liquorice and 0.5-3g of pangolin; the traditional Chinese medicine prescription for treating uterine diseases is administrated by selecting umbilical points, can treat female gynecological diseases such as hysteromyoma, ovarian cyst, endometritis, pelvic inflammation, adnexitis, cervical erosion, menstrual disorder, dysmenorrheal and the like, achieves the effects of eliminating stagnation without damaging the body resistance, eliminating evil and strengthening the body resistance, treats both principal and secondary aspect of diseases, and has the beneficial effects of an effective prescription for eliminating stagnation and removing stasis, breaking stagnation and eliminating mass, promoting qi circulation and relieving pain, and warming uterus and nourishing blood.
Description
Technical Field
The invention relates to the technical field of Chinese herbal medicine products, in particular to a Chinese medicinal prescription for treating uterine diseases, which is applied through the acupoint in the umbilicus and has a treatment effect on female gynecological diseases such as hysteromyoma, ovarian cyst, endometritis, pelvic inflammation, adnexitis, cervical erosion, menstrual disorder, dysmenorrheal and the like.
Background
Hysteromyoma, pelvic inflammatory disease, adnexitis, ovarian cyst, menoxenia and dysmenorrhea are common diseases and frequently encountered diseases of adult women. Of the clinical gynecological patients, two thirds of the patients are the disease, and the incidence rate is high. Modern medicine only uses sex hormone or operation to radically cure hysteromyoma, and western medicine treats gynecological inflammation such as pelvic inflammation and the like and uses antibiotic medicines, so that the treatment method has the disadvantages of multiple defects, single effect, high recurrence rate and difficult acceptance of many patients. The traditional Chinese medicine generally treats based on syndrome differentiation, but oral administration mostly causes low blood concentration of lesion parts, long sandalwood treatment, inconvenient administration and difficult cure, and no specific medicine or brand new treatment method exists at present.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a traditional Chinese medicine prescription for treating uterine diseases, which can treat female gynecological diseases such as hysteromyoma, ovarian cyst, endometritis, pelvic inflammation, adnexitis, cervical erosion, menstrual disorder, dysmenorrheal and the like, achieves the purposes of eliminating stagnation without damaging the body resistance, eliminating evil and strengthening the body resistance, treating both symptoms and root causes, and has the effective prescription for eliminating stagnation and removing stasis, breaking stagnation and eliminating mass, promoting qi circulation and relieving pain, warming uterus and nourishing blood.
The technical scheme for solving the problems is that the traditional Chinese medicine formula for treating the uterine diseases is prepared from the following raw materials in parts by weight: 6-12g of curcuma zedoary, 6-15g of rhizoma sparganii, 5-12g of motherwort herb, 2-10g of fructus evodiae, 1-6g of fried dried ginger, 2-10g of folium artemisiae argyi, 3-9g of achyranthes bidentata, 5-12g of angelica, 3-9g of moutan bark, 3-9g of rhizoma corydalis, 3-9g of rhizoma cyperi, 3-9g of radix paeoniae alba, 3-9g of salvia miltiorrhiza, 3-9g of cassia twig, 3-9g of ligusticum wallichii, 1-6g of liquorice and 0.5-3g of pangolin;
the dosage form of the traditional Chinese medicine can be powder and paste;
the administration mode of the traditional Chinese medicine formula can be external transdermal absorption;
the preparation method of the powder can comprise the following steps:
and (3) crushing: mixing the raw materials according to a ratio, and putting the mixture into a pulverizer to pulverize into fine powder with the granularity of 130 meshes;
and (3) mixing: putting the fine powder obtained in the step into a mixing stirrer to be fully and uniformly mixed;
and (3) packaging: subpackaging the uniformly mixed fine powder by packaging bags, wherein each 10g of the fine powder is packaged by one bag, and each 10 bags of the fine powder are packaged by one box;
the using method comprises the following steps: the bagged powder is applied to the umbilicus acupoint for transdermal absorption;
the preparation method of the paste can comprise the following steps:
the clear paste preparation step: mixing the raw materials according to a ratio, decocting, separating, collecting volatile oil, and heating and concentrating the volatile oil to obtain clear paste with the relative density of 1.25-1.35;
baking and crushing; baking the fluid extract with drying equipment until the fluid extract becomes dry extract, pulverizing the dry extract in pulverizing equipment, and sieving the pulverized dry extract with 80 mesh sieve to obtain dry extract powder;
and (3) mixing: melting 10-20g of fatty glyceride in water bath, mixing with dry extract powder and 1-10g of azone, and mixing to obtain unguent;
the using method comprises the following steps: the paste is applied to the umbilicus acupoint for transdermal absorption.
The beneficial effects of the invention are: the traditional Chinese medicine prescription for treating the uterine diseases is administrated by selecting the acupoint in the navel, can treat female gynecological diseases such as hysteromyoma, ovarian cyst, endometritis, pelvic inflammatory disease, adnexitis, cervical erosion, menstrual disorder, dysmenorrheal and the like, achieves the effects of eliminating stasis without damaging body resistance, eliminating evil and strengthening body resistance, treats both symptoms and root causes, and has the beneficial effects of an effective prescription for eliminating stagnation and removing stasis, breaking stagnation and eliminating mass, promoting qi circulation and relieving pain, and warming uterus and nourishing blood.
The specific implementation mode is as follows:
the specific implementation mode of the invention is that the raw materials of the traditional Chinese medicine for treating uterine diseases comprise the following components: 6-12g of curcuma zedoary, 6-15g of rhizoma sparganii, 5-12g of motherwort herb, 2-10g of fructus evodiae, 1-6g of fried dried ginger, 2-10g of folium artemisiae argyi, 3-9g of achyranthes bidentata, 5-12g of angelica, 3-9g of moutan bark, 3-9g of rhizoma corydalis, 3-9g of rhizoma cyperi, 3-9g of radix paeoniae alba, 3-9g of salvia miltiorrhiza, 3-9g of cassia twig, 3-9g of ligusticum wallichii, 1-6g of liquorice and 0.5-3g of pangolin; in the formula, the zedoary and the sanluo are pungent and warm in property, break blood and promote qi circulation, remove food retention and relieve pain, and the two are mutually reinforced and are used as monarch drugs; motherwort, salvia miltiorrhiza, corydalis tuber, tree peony bark, szechuan lovage rhizome and nutgrass galingale rhizome are used as auxiliary materials for activating blood and stimulating menstrual flow, promoting qi circulation and relieving pain, and the auxiliary materials are used as ministerial drugs for promoting blood circulation and removing stasis; fructus evodiae, fried rhizoma zingiberis, cassia twig and folium artemisiae argyi have the effects of warming yang and stimulating the menstrual flow, warming uterus and dispelling cold, angelica and radix paeoniae alba have the effects of nourishing blood and enriching blood, achyranthes and pangolin have the effects of inducing blood to descend, activating blood and eliminating abdominal mass, and are used as adjuvant drugs for assisting monarch and minister drugs in eliminating evil and strengthening body resistance without damaging body resistance; the liquorice tonifies the middle-jiao and the Qi, and is used as a guiding drug for blending various medicines; the whole formula has the effects of removing food retention and eliminating mass, promoting qi circulation and relieving pain, and warming uterus and nourishing blood. Can be used for treating blood stasis type hysteromyoma, uterus hypertrophy, menoxenia, dysmenorrhea, ovarian cyst, pelvic inflammatory disease, and adnexitis.
Claims (5)
1. A traditional Chinese medicine prescription for treating uterine diseases is characterized in that: the traditional Chinese medicine formula comprises the following raw materials in parts by weight: 6-12g of curcuma zedoary, 6-15g of rhizoma sparganii, 5-12g of motherwort, 2-10g of fructus evodiae, 1-6g of fried dried ginger, 2-10g of folium artemisiae argyi, 3-9g of achyranthes bidentata, 5-12g of angelica, 3-9g of moutan bark, 3-9g of rhizoma corydalis, 3-9g of rhizoma cyperi, 3-9g of radix paeoniae alba, 3-9g of salvia miltiorrhiza, 3-9g of cassia twig, 3-9g of ligusticum wallichii, 1-6g of liquorice and 0.5-3g of pangolin.
2. The traditional Chinese medicine prescription for treating uterine diseases according to claim 1, which is characterized in that: the dosage form of the traditional Chinese medicine can be powder and ointment.
3. The Chinese medicinal formula for treating the uterine disease according to claim 1, which is characterized in that: the administration mode of the traditional Chinese medicine formula can be external transdermal absorption.
4. A Chinese medicinal formulation for treating uterine diseases according to claim 2, which is characterized in that: the preparation method of the powder can comprise the following steps:
and (3) crushing: mixing the raw materials according to a ratio, and putting the mixture into a pulverizer to pulverize into fine powder with the granularity of 130 meshes;
and (3) mixing: putting the fine powder obtained in the step into a mixing stirrer to be fully and uniformly mixed;
and (3) packaging: subpackaging the uniformly mixed fine powder by packaging bags, wherein each 10g of the fine powder is packaged by one bag, and each 10 bags of the fine powder are packaged by one box;
the using method comprises the following steps: the bagged powder is applied to the umbilicus acupoint for transdermal absorption.
5. A Chinese medicinal formulation for treating uterine diseases according to claim 2, which is characterized in that: the preparation method of the paste can comprise the following steps:
the clear paste preparation step: mixing the raw materials according to a ratio, decocting, separating, collecting volatile oil, and heating and concentrating the volatile oil to obtain clear paste with the relative density of 1.25-1.35;
baking and crushing; baking the fluid extract with drying equipment until the fluid extract becomes dry extract, pulverizing the dry extract in pulverizing equipment, and sieving the pulverized dry extract with 80 mesh sieve to obtain dry extract powder;
and (3) mixing: melting 10-20g of fatty glyceride in water bath, mixing with dry extract powder and 1-10g of azone, and mixing to obtain unguent;
the using method comprises the following steps: the paste is applied to the umbilicus acupoint for transdermal absorption.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111660526.9A CN115006509A (en) | 2021-12-31 | 2021-12-31 | Chinese medicinal formula for treating uterine diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111660526.9A CN115006509A (en) | 2021-12-31 | 2021-12-31 | Chinese medicinal formula for treating uterine diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115006509A true CN115006509A (en) | 2022-09-06 |
Family
ID=83065063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111660526.9A Pending CN115006509A (en) | 2021-12-31 | 2021-12-31 | Chinese medicinal formula for treating uterine diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115006509A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049472A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by endometriosis |
| CN101780160A (en) * | 2010-04-07 | 2010-07-21 | 史长山 | Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof |
| CN106177845A (en) * | 2016-08-10 | 2016-12-07 | 张成莲 | Palace disease patch |
-
2021
- 2021-12-31 CN CN202111660526.9A patent/CN115006509A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049472A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by endometriosis |
| CN101780160A (en) * | 2010-04-07 | 2010-07-21 | 史长山 | Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof |
| CN106177845A (en) * | 2016-08-10 | 2016-12-07 | 张成莲 | Palace disease patch |
Non-Patent Citations (1)
| Title |
|---|
| 晓玲;: "热敏灸结合中药治疗原发性痛经的疗效观察", 光明中医, vol. 30, no. 05, pages 1020 - 1022 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN102657835B (en) | Composition and medical liquor for treatment of high blood pressure/rheumatoid arthritis and preparation method and application of composition and medical liquor | |
| CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN101708297A (en) | Medicament for treating gout disease | |
| CN101961458B (en) | Oral medicament for treating osteonecrosis of femoral head | |
| CN110624040A (en) | Pharmaceutical preparation for treating fracture injury at middle stage and preparation method thereof | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
| ES2355289T3 (en) | THERAPEUTIC AGENTS FOR ULCERATIVE COLITIS. | |
| CN110624033A (en) | Traditional Chinese medicine for reunion of bone and tendon and preparation method thereof | |
| CN102416126A (en) | Chinese medicinal combination preparation for treating behcet syndrome and preparation method of Chinese medicinal combination preparation | |
| CN103341013B (en) | A kind of Chinese medicine for the treatment of lumbago and skelalgia | |
| CN104940591A (en) | Plaster for treating lumbar disc herniation | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
| CN115006509A (en) | Chinese medicinal formula for treating uterine diseases | |
| CN106668782A (en) | External traditional Chinese medicine preparation for treating knee osteoarthritis and preparation method thereof | |
| CN103520421A (en) | Chinese medicinal composition for treating armpit odor | |
| CN113318180A (en) | A Chinese medicinal composition for treating traumatic injury, and its preparation method | |
| CN111658748A (en) | Composition for treating dysmenorrhea, oral preparation and application | |
| CN104547489A (en) | Use of traditional Chinese medicine composition in preparation of medicine for treating comminuted fracture | |
| CN101112443A (en) | Grass red capsule for treating gynaecologic leucorrhoea disease and method for preparing the same | |
| CN104758466A (en) | Traditional Chinese medicine preparation for treating acute cholecystitis and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220906 |